References
- Cicek E, Sutcu R, Gokalp O, Yilmaz HR, Ozer MK, Uz E, Ozcelik N, Delibas N. The effects of isoniazid on hippocampal NMDA receptors: Protective role of erdosteine. Mol Cell Biochem 2005, 277, 131–135.
- Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: Diversity, development and disease. Curr Opin Neurobiol 2001, 11, 327–335.
- Waxman EA, Lynch DR. N-methyl-D-aspartate receptor subtypes: Multiple roles in excitotoxicity and neurological disease. Neuroscientist 2005, 11, 37–49.
- Eckles-Smith K, Clayton D, Bickford P, Browning MD. Caloric restriction prevents age-related deficits in LTP and in NMDA receptor expression. Brain Res Mol Brain Res 2000, 78, 154–162.
- Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12, 529–540.
- Gwag BJ, Lee YA, Ko SY, Lee MJ, Im DS, Yun BS, Lim HR, Park SM, Byun HY, Son SJ, Kwon HJ, Lee JY, Cho JY, Won SJ, Kim KW, Ahn YM, Moon HS, Lee HU, Yoon SH, Noh JH, Chung JM, Cho SI. Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine. J Cereb Blood Flow Metab 2007, 27, 1142–1151.
- AD 2000 Coloborative Group Aspirin in Alzheimer’s disease: A randomized open-label trial. Lancet Neurol 2008, 7, 41–49.
- Gilroy DW, Tomlinson A, Willoughby DA. Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm Res 1998, 47, 79–85.
- Mateos R, Lecumberri E, Ramos S, Goya L, Bravo L. Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress. Application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J Chromatogr B Analyt Technol Biomed Life Sci 2005, 827, 76–82.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193, 265–275.
- Gultekin F, Karakoyun I, Sutcu R, Savik E, Cesur G, Orhan H, Delibas N. Chlorpyrifos increases the levels of hippocampal NMDA receptor subunits NR2A and NR2B in juvenile and adult rats. Int J Neurosci 2007, 117, 47–62.
- Heresco Heresco-Levy U. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality. Progr Neuro Psychopharmacol Biol Psychiatr 2003, 27, 1113–1123.
- Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998, 54, 581–618.
- Santucci DM, Raghavachari S. The effects of NR2 subunit-dependent NMDA receptor kinetics on synaptic transmission and CaMKII activation. PLoS Comput Biol 2008, 4, e1000208.
- DelibasN Kilinc, I, Yonden Z et al. NMDA receptor subunits 2A and 2B decrease and lipid peroxidation increase in the hippocampus of streptozotocin-diabetic rats: Effects of insulin and gliclazide treatments. Intern J Neuroscience 2004, 114, 391–401.
- Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ. Genetic enhancement of learning and memory in mice. Nature 1999, 401, 63–69.
- Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990, 13, 171–182.
- Heintz N, Zoghbi HY. Insights from mouse models into the molecular basis of neurodegeneration. Annu Rev Physiol 2000, 62, 779–802.
- Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 2000, 293, 417–425.
- Crisanti P, Laplace O, Lecain E, Jonet L, Jeanny JC, Omri B. The role of PKCzeta in NMDA-induced retinal ganglion cell death: Prevention by aspirin. Apoptosis 2006, 11, 983–991.
- Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 2005, 58, 730–735.
- Hacioglu G, Agar A, Ozkaya G, Yargicoglu P, Gumuslu S. The effect of different hypertension models on visual evoked potentials. Int J Neurosci 2002, 112, 1321–1335.
- Corrêa Mde C, Maldonado P, da Rosa CS, Lunkes G, Lunkes DS, Kaizer RR, Ahmed M, Morsch VM, Pereira ME, Schetinger MR. Oxidative stress and erythrocyte acetylcholinesterase (AChE) in hypertensive and ischemic patients of both acute and chronic stages. Biomed Pharmacother 2008, 62, 317–324.
- Markesbery WR. Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 1997, 23, 134–147.